세계의 바이오 프로세싱 시장 : 기회와 전략(-2034년)

Bioprocessing refers to the use of living cells or their components (such as enzymes, bacteria, or yeast) to obtain desired products, particularly in the production of pharmaceuticals, biofuels, chemicals, and food ingredients. It is an essential part of biotechnology manufacturing, especially for complex biological therapies that cannot be synthesized chemically. Bioprocessing is primarily used in the biopharmaceutical industry to manufacture biologics such as monoclonal antibodies, vaccines, hormones, enzymes, and cell and gene therapies. These products are used across a wide range of medical treatments, including cancer, autoimmune disorders, infectious diseases, and rare genetic conditions.

The global bioprocessing market reached a value of nearly $62,344.10 million in 2024, having grown at a compound annual growth rate (CAGR) of 12.93% since 2019. The market is expected to grow from $62,344.10 million in 2024 to $122,677.10 million in 2029 at a rate of 14.50%. The market is then expected to grow at a CAGR of 13.45% from 2029 and reach $230,550.77 million in 2034.

Expansion Of Pharmaceutical And Biotechnology Industries

During the historic period, the bioprocessing market was mainly driven by the expansion of pharmaceutical and biotechnology industries. As pharmaceutical and biotech firms grew in scale and scope, the demand for efficient, reliable bioprocessing systems, such as fermenters, bioreactors, downstream purification, and automation, rose significantly. These technologies enabled mass production of biologics, vaccines, and biosimilars, helping meet rising healthcare demands while ensuring quality and regulatory compliance. For instance, in June 2025, according to the Eliquent Japan, a regulatory consulting firm supporting biotech and pharmaceutical companies, published by MixOnline (a magazine), Japan's pharmaceutical market for FY2024 (April 2024 - March 2025) reached 11.4874 trillion yen ($76.82 billion, based on NHI price), representing a 1% increase from the previous year. This marks the second consecutive year the market has remained above 11 trillion yen ($73.56 billion), achieving a new record high in fiscal year terms. Furthermore, in May 2025, according to a presentation by India Brand Equity Foundation (IBEF), a trust established by the Government of India to promote and showcase India's business, economic, and investment potential globally, India's biotechnology industry expanded from $ 10 billion in 2015 to $ 130 billion in 2024, with expectations to reach US$ 150 billion by 2025. Therefore, throughout the historic period, the growth of pharmaceutical and biotechnology industries served as a principal driver for the bioprocessing market.

Expansion of Automated Cell and Gene Therapy Manufacturing in Emerging Markets

Companies in the market are focusing on expanding automated cell and gene therapy manufacturing capabilities in emerging markets to meet growing global demand and reduce production costs. Automation enhances process consistency, scalability, and regulatory compliance, which are critical for complex therapies. This expansion allows localized manufacturing, improving accessibility and reducing supply chain challenges. As a result, it drives increased adoption of advanced bioprocessing technologies tailored for high-efficiency, large-scale production. For example, in October 2024, Terumo Blood and Cell Technologies, a US-based medical technology company, expanding its offerings in Latin America to help bring automated manufacturing to cell and gene therapy companies in Brazil, Colombia and Mexico. Cell and gene therapies are a rapidly advancing field and hold the potential to treat diseases and transform lives. Affordability and the ability to scale these treatments in the manufacturing process are key factors that make automated technologies promising in helping cell and gene therapies touch more patients' lives. This is especially important in Latin America, where there is a heavy reliance on government healthcare systems.

The global bioprocessing market is fairly fragmented, with a large number of small players operating in the market. The top ten competitors in the market made up to 23.04% of the total market in 2024.

Bioprocessing Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global bioprocessing market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for bioprocessing? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The bioprocessing market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider bioprocessing market; and compares it with other markets.

The report covers the following chapters

• Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by application, by end user, by scale of operation and by product.
• Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Growth Analysis And Strategic Analysis Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
• Global Market Size And Growth - Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods
• Regional And Country Analysis - Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
• Market Segmentation - Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by type, by application, by end user, by scale of operation and by product in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
• Regional Market Size and Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
• Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
• Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for bioprocessing market providers in terms of product/service offerings geographic expansion, marketing strategies and target groups next five years.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Type: Upstream Processing; Downstream Processing
• 2) By Application: Monoclonal Antibodies; Cell And Gene Therapy; Vaccines; Other Applications
• 3) By End User: Biopharmaceutical Companies; Contract Manufacturing Organizations; Academic Research Institutes; Other End Users
• 4) By Scale Of Operation: Commercial Scale; Preclinical; Clinical
• 5) By Product: Equipment; Consumables; Services
• Companies Mentioned: Sartorius AG (Novasep); Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA (MilliporeSigma); Lonza Group AG
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; bioprocessing indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Bioprocessing - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Bioprocessing Market Definition And Segmentations
• 6.4 Market Segmentation By Type
  • 6.4.1 Upstream Processing
  • 6.4.2 Downstream Processing
• 6.5 Market Segmentation By Application
  • 6.5.1 Monoclonal Antibiotics
  • 6.5.2 Cell And Gene Therapy
  • 6.5.3 Vaccines
  • 6.5.4 Other Applications
• 6.6 Market Segmentation By End User
  • 6.6.1 Biopharmaceutical Companies
  • 6.6.2 Contract Manufacturing Organizations
  • 6.6.3 Academic Research Institutes
  • 6.6.4 Other End Users
• 6.7 Market Segmentation By Scale Of Operation
  • 6.7.1 Commercial Scale
  • 6.7.2 Clinical
  • 6.7.3 Preclinical
• 6.8 Market Segmentation By Product
  • 6.8.1 Equipment
  • 6.8.2 Consumables
  • 6.8.3 Services

7 Major Market Trends

• 7.1 Merging Spectral Cytometry With Real-Time Imaging
• 7.2 Expansion of Automated Cell and Gene Therapy Manufacturing in Emerging Markets
• 7.3 Development Of Refining Tangential Flow Filtration (TFF) Consumables
• 7.4 Shift Toward Animal-Free and In Vitro Pyrogen Testing
• 7.5 Advancement of High-Parameter Spectral Flow Cytometry for Drug Discovery & Cellular Analysis
• 7.6 Introduction of the CHO Edge System Gen-4 for Next-Gen Cell Line Development
• 7.7 Development Of Rapid Animal-Free Bacterial Endotoxin Test

8 Global Bioprocessing Growth Analysis And Strategic Analysis Framework

• 8.1 Global Bioprocessing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors)
  • 8.1.1 Political
  • 8.1.2 Economic
  • 8.1.3 Social
  • 8.1.4 Technological
  • 8.1.5 Environmental
  • 8.1.6 Legal
• 8.2 End Users of B2B Market
  • 8.2.1 Biopharmaceutical Companies
  • 8.2.2 Contract Manufacturing Organizations
  • 8.2.3 Academic Research Institutes
  • 8.2.4 Other End Users
• 8.3 Global Bioprocessing Market Size And Growth Analysis
• 8.4 Historic Market Growth, 2019 - 2024, Value ($ Million)
  • 8.4.1 Market Drivers 2019 - 2024
  • 8.4.2 Market Restraints 2019 - 2024
• 8.5 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
• 8.6 Forecast Growth Contributors/Factors
  • 8.6.1 Quantitative Growth Contributors
  • 8.6.2 Drivers
  • 8.6.3 Restraints
• 8.7 Global Bioprocessing Total Addressable Market (TAM)

9 Global Bioprocessing Market Segmentation

• 9.1 Global Bioprocessing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.2 Global Bioprocessing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.3 Global Bioprocessing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.4 Global Bioprocessing Market, Segmentation By Scale Of Operation, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.5 Global Bioprocessing Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.6 Global Bioprocessing Market, Sub-Segmentation Of Upstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.7 Global Bioprocessing Market, Sub-Segmentation By Downstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 Bioprocessing Market, Regional and Country Analysis

• 10.1 Global Bioprocessing Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 10.2 Global Bioprocessing Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

• 11.1 Summary
• 11.2 Market Overview
  • 11.2.1 Region Information
  • 11.2.2 Market Information
  • 11.2.3 Background Information
  • 11.2.4 Government Initiatives
  • 11.2.5 Regulations
  • 11.2.6 Regulatory Bodies
  • 11.2.7 Major Associations
  • 11.2.8 Taxes Levied
  • 11.2.9 Corporate Tax Structure
  • 11.2.10 Investments
  • 11.2.11 Major Companies
• 11.3 Asia Pacific Bioprocessing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.4 Asia Pacific Bioprocessing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.5 Asia Pacific Bioprocessing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.6 Asia Pacific Bioprocessing Market, Sub-Segmentation Of Upstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.7 Asia Pacific Bioprocessing Market, Sub-Segmentation By Downstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.8 Asia-Pacific Bioprocessing Market: Country Analysis
• 11.9 China Market
• 11.10 Summary
• 11.11 Market Overview
  • 11.11.1 Country Information
  • 11.11.2 Market Information
  • 11.11.3 Background Information
  • 11.11.4 Government Initiatives
  • 11.11.5 Regulations
  • 11.11.6 Regulatory Bodies
  • 11.11.7 Major Associations
  • 11.11.8 Taxes Levied
  • 11.11.9 Corporate Tax Structure
  • 11.11.10 Investments
  • 11.11.11 Major Companies
• 11.12 China Bioprocessing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.13 China Bioprocessing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.14 China Bioprocessing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.15 China Bioprocessing Market, Sub-Segmentation Of Upstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.16 China Bioprocessing Market, Sub-Segmentation By Downstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.17 India Market
• 11.18 India Bioprocessing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.19 India Bioprocessing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.20 India Bioprocessing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.21 India Bioprocessing Market, Sub-Segmentation Of Upstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.22 India Bioprocessing Market, Sub-Segmentation By Downstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.23 Japan Market
• 11.24 Summary
• 11.25 Market Overview
  • 11.25.1 Country Information
  • 11.25.2 Market Information
  • 11.25.3 Background Information
  • 11.25.4 Government Initiatives
  • 11.25.5 Regulations
  • 11.25.6 Regulatory Bodies
  • 11.25.7 Major Associations
  • 11.25.8 Taxes Levied
  • 11.25.9 Corporate Tax Structure
  • 11.25.10 Investments
  • 11.25.11 Major Companies
• 11.26 Japan Bioprocessing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.27 Japan Bioprocessing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.28 Japan Bioprocessing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.29 Japan Bioprocessing Market, Sub-Segmentation Of Upstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.30 Japan Bioprocessing Market, Sub-Segmentation By Downstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.31 Australia Market
• 11.32 Australia Bioprocessing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.33 Australia Bioprocessing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.34 Australia Bioprocessing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.35 Australia Bioprocessing Market, Sub-Segmentation Of Upstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.36 Australia Bioprocessing Market, Sub-Segmentation By Downstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.37 Indonesia Market
• 11.38 Indonesia Bioprocessing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.39 Indonesia Bioprocessing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.40 Indonesia Bioprocessing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.41 Indonesia Bioprocessing Market, Sub-Segmentation Of Upstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.42 Indonesia Bioprocessing Market, Sub-Segmentation By Downstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.43 South Korea Market
• 11.44 Summary
• 11.45 Market Overview
  • 11.45.1 Country Information
  • 11.45.2 Market Information
  • 11.45.3 Background Information
  • 11.45.4 Government Initiatives
  • 11.45.5 Regulations
  • 11.45.6 Regulatory Bodies
  • 11.45.7 Major Associations
  • 11.45.8 Taxes Levied
  • 11.45.9 Corporate Tax Structure
  • 11.45.10 Investments
  • 11.45.11 Major Companies
• 11.46 South Korea Bioprocessing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.47 South Korea Bioprocessing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.48 South Korea Bioprocessing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.49 South Korea Bioprocessing Market, Sub-Segmentation Of Upstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.50 South Korea Bioprocessing Market, Sub-Segmentation By Downstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

• 12.1 Summary
• 12.2 Market Overview
  • 12.2.1 Region Information
  • 12.2.2 Market Information
  • 12.2.3 Background Information
  • 12.2.4 Government Initiatives
  • 12.2.5 Regulations
  • 12.2.6 Regulatory Bodies
  • 12.2.7 Major Associations
  • 12.2.8 Taxes Levied
  • 12.2.9 Corporate tax structure
  • 12.2.10 Investments
  • 12.2.11 Major Companies
• 12.3 Western Europe Bioprocessing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.4 Western Europe Bioprocessing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.5 Western Europe Bioprocessing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.6 Western Europe Bioprocessing Market, Sub-Segmentation Of Upstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.7 Western Europe Bioprocessing Market, Sub-Segmentation By Downstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.8 UK Market
• 12.9 UK Bioprocessing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.10 UK Bioprocessing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.11 UK Bioprocessing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.12 UK Bioprocessing Market, Sub-Segmentation Of Upstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.13 UK Bioprocessing Market, Sub-Segmentation By Downstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.14 Germany Market
• 12.15 Germany Bioprocessing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.16 Germany Bioprocessing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.17 Germany Bioprocessing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.18 Germany Bioprocessing Market, Sub-Segmentation Of Upstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.19 Germany Bioprocessing Market, Sub-Segmentation By Downstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.20 France Market
• 12.21 France Bioprocessing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.22 France Bioprocessing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.23 France Bioprocessing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.24 France Bioprocessing Market, Sub-Segmentation Of Upstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.25 France Bioprocessing Market, Sub-Segmentation By Downstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.26 Italy Market
• 12.27 Italy Bioprocessing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.28 Italy Bioprocessing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.29 Italy Bioprocessing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.30 Italy Bioprocessing Market, Sub-Segmentation Of Upstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.31 Italy Bioprocessing Market, Sub-Segmentation By Downstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.32 Spain Market
• 12.33 Spain Bioprocessing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.34 Spain Bioprocessing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.35 Spain Bioprocessing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.36 Spain Bioprocessing Market, Sub-Segmentation Of Upstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.37 Spain Bioprocessing Market, Sub-Segmentation By Downstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

• 13.1 Summary
• 13.2 Market Overview
  • 13.2.1 Region Information
  • 13.2.2 Market Information
  • 13.2.3 Background Information
  • 13.2.4 Government Initiatives
  • 13.2.5 Regulations
  • 13.2.6 Regulatory Bodies
  • 13.2.7 Major Associations
  • 13.2.8 Taxes Levied
  • 13.2.9 Corporate Tax Structure
  • 13.2.10 Investments
  • 13.2.11 Major companies
• 13.3 Eastern Europe Bioprocessing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.4 Eastern Europe Bioprocessing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.5 Eastern Europe Bioprocessing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.6 Eastern Europe Bioprocessing Market, Sub-Segmentation Of Upstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.7 Eastern Europe Bioprocessing Market, Sub-Segmentation By Downstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.8 Russia Market
• 13.9 Russia Bioprocessing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.10 Russia Bioprocessing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.11 Russia Bioprocessing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.12 Russia Bioprocessing Market, Sub-Segmentation Of Upstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.13 Russia Bioprocessing Market, Sub-Segmentation By Downstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

• 14.1 Summary
• 14.2 Market Overview
  • 14.2.1 Region Information
  • 14.2.2 Market Information
  • 14.2.3 Background Information
  • 14.2.4 Government Initiatives
  • 14.2.5 Regulations
  • 14.2.6 Regulatory Bodies
  • 14.2.7 Major Associations
  • 14.2.8 Taxes Levied
  • 14.2.9 Corporate Tax Structure
  • 14.2.10 Investments
  • 14.2.11 Major Companies
• 14.3 North America Bioprocessing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.4 North America Bioprocessing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.5 North America Bioprocessing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.6 North America Bioprocessing Market, Sub-Segmentation Of Upstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.7 North America Bioprocessing Market, Sub-Segmentation By Downstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.8 North America Bioprocessing Market: Country Analysis
• 14.9 USA Market
• 14.10 Summary
• 14.11 Market Overview
  • 14.11.1 Country Information
  • 14.11.2 Market Information
  • 14.11.3 Background Information
  • 14.11.4 Government Initiatives
  • 14.11.5 Regulations
  • 14.11.6 Regulatory Bodies
  • 14.11.7 Major Associations
  • 14.11.8 Taxes Levied
  • 14.11.9 Corporate Tax Structure
  • 14.11.10 Investments
  • 14.11.11 Major Companies
• 14.12 USA Bioprocessing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.13 USA Bioprocessing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.14 USA Bioprocessing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.15 USA Bioprocessing Market, Sub-Segmentation Of Upstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.16 USA Bioprocessing Market, Sub-Segmentation By Downstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.17 Canada Market
• 14.18 Summary
• 14.19 Market Overview
  • 14.19.1 Country Information
  • 14.19.2 Market Information
  • 14.19.3 Background Information
  • 14.19.4 Government Initiatives
  • 14.19.5 Regulations
  • 14.19.6 Regulatory Bodies
  • 14.19.7 Major Associations
  • 14.19.8 Taxes Levied
  • 14.19.9 Corporate Tax Structure
  • 14.19.10 Investments
  • 14.19.11 Major Companies
• 14.20 Canada Bioprocessing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.21 Canada Bioprocessing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.22 Canada Bioprocessing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.23 Canada Bioprocessing Market, Sub-Segmentation Of Upstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.24 Canada Bioprocessing Market, Sub-Segmentation By Downstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

• 15.1 Summary
• 15.2 Market Overview
  • 15.2.1 Region Information
  • 15.2.2 Market Information
  • 15.2.3 Background Information
  • 15.2.4 Government Initiatives
  • 15.2.5 Regulations
  • 15.2.6 Regulatory Bodies
  • 15.2.7 Major Associations
  • 15.2.8 Taxes Levied
  • 15.2.9 Corporate Tax Structure
  • 15.2.10 Investments
  • 15.2.11 Major Companies
• 15.3 South America Bioprocessing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.4 South America Bioprocessing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.5 South America Bioprocessing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.6 South America Bioprocessing Market, Sub-Segmentation Of Upstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.7 South America Bioprocessing Market, Sub-Segmentation By Downstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.8 South America Bioprocessing Market: Country Analysis
• 15.9 Brazil Market
• 15.10 Brazil Bioprocessing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.11 Brazil Bioprocessing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.12 Brazil Bioprocessing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.13 Brazil Bioprocessing Market, Sub-Segmentation Of Upstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.14 Brazil Bioprocessing Market, Sub-Segmentation By Downstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

• 16.1 Summary
• 16.2 Market Overview
  • 16.2.1 Region Information
  • 16.2.2 Market Information
  • 16.2.3 Background Information
  • 16.2.4 Government Initiatives
  • 16.2.5 Regulations
  • 16.2.6 Regulatory Bodies
  • 16.2.7 Major Associations
  • 16.2.8 Taxes Levied
  • 16.2.9 Corporate Tax Structure
  • 16.2.10 Investments
  • 16.2.11 Major Companies
• 16.3 Middle East Bioprocessing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 16.4 Middle East Bioprocessing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 16.5 Middle East Bioprocessing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 16.6 Middle East Bioprocessing Market, Sub-Segmentation Of Upstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 16.7 Middle East Bioprocessing Market, Sub-Segmentation By Downstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

• 17.1 Summary
• 17.2 Market Overview
  • 17.2.1 Region Information
  • 17.2.2 Market Information
  • 17.2.3 Background Information
  • 17.2.4 Government Initiatives
  • 17.2.5 Regulations
  • 17.2.6 Regulatory Bodies
  • 17.2.7 Major Associations
  • 17.2.8 Taxes Levied
  • 17.2.9 Corporate Tax Structure
  • 17.2.10 Major Companies
• 17.3 Africa Bioprocessing Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 17.4 Africa Bioprocessing Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 17.5 Africa Bioprocessing Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 17.6 Africa Bioprocessing Market, Sub-Segmentation Of Upstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 17.7 Africa Bioprocessing Market, Sub-Segmentation By Downstream Processing, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

• 18.1 Company Profiles
• 18.2 Sartorius AG (Novasep)
  • 18.2.1 Company Overview
  • 18.2.2 Products And Services
  • 18.2.3 Business Strategy
  • 18.2.4 Financial Overview
• 18.3 Thermo Fisher Scientific Inc
  • 18.3.1 Company Overview
  • 18.3.2 Products And Services
  • 18.3.3 Business Strategy
  • 18.3.4 Financial Overview
• 18.4 Danaher Corporation
  • 18.4.1 Company Overview
  • 18.4.2 Products And Services
  • 18.4.3 Business Strategy
  • 18.4.4 Financial Overview
• 18.5 Merck KGaA (MilliporeSigma)
  • 18.5.1 Company Overview
  • 18.5.2 Products And Services
  • 18.5.3 Business Strategy
  • 18.5.4 Financial Overview
• 18.6 Lonza Group AG
  • 18.6.1 Company Overview
  • 18.6.2 Products And Services
  • 18.6.3 Business Strategy
  • 18.6.4 Financial Overview

19 Other Major And Innovative Companies

• 19.1 Agilent Technologies Inc.
  • 19.1.1 Company Overview:
  • 19.1.2 Products and Services:
• 19.2 Cytiva AB
  • 19.2.1 Company Overview:
  • 19.2.2 Products and Services:
• 19.3 Bristol Myers Squibb Company
  • 19.3.1 Company Overview:
  • 19.3.2 Products and Services:
• 19.4 GE Healthcare Technologies, Inc.
  • 19.4.1 Company Overview:
  • 19.4.2 Products and Services:
• 19.5 Pfizer Inc.
  • 19.5.1 Company Overview:
  • 19.5.2 Products and Services:
• 19.6 Boehringer Ingelheim GmbH
  • 19.6.1 Company Overview:
  • 19.6.2 Products and Services:
• 19.7 Samsung Biologics Co., Ltd.
  • 19.7.1 Company Overview:
  • 19.7.2 Products and Services:
• 19.8 Catalent Inc.
  • 19.8.1 Company Overview:
  • 19.8.2 Products and Services:
• 19.9 Repligen Corporation
  • 19.9.1 Company Overview:
  • 19.9.2 Products and Services:
• 19.10 Waters Corporation
  • 19.10.1 Company Overview:
  • 19.10.2 Products and Services:
• 19.11 Getinge AB (Applikon Biotechnology B.V.)
  • 19.11.1 Company Overview:
  • 19.11.2 Products and Services:
• 19.12 Fujifilm Healthcare Corporation
  • 19.12.1 Company Overview:
  • 19.12.2 Products and Services:
• 19.13 Amgen Inc.
  • 19.13.1 Company Overview:
  • 19.13.2 Products and Services:
• 19.14 Bio-Rad Laboratories Inc.
  • 19.14.1 Company Overview:
  • 19.14.2 Products and Services:
• 19.15 Wuxi Biologics Inc.
  • 19.15.1 Company Overview:
  • 19.15.2 Products and Services:

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

• 22.1 Artis Acquired Landmark Bio
• 22.2 Sartorius Stedim Biotech Acquired Polyplus
• 22.3 Asahi Kasei Medical Acquired Bionova Scientific

23 Recent Developments In The Bioprocessing Market

• 23.1 Launch of Advanced Live-Cell Analysis System for 3D Cell Culture Applications
• 23.2 Launch of Automated Microbial Colony Picking System to Streamline Screening Workflows
• 23.3 Expansion of Single-Use Bioreactor Capacity With the Xcellerex X-Platform

24 Opportunities And Strategies

• 24.1 Global Bioprocessing Market In 2029 - Countries Offering Most New Opportunities
• 24.2 Global Bioprocessing Market In 2029 - Segments Offering Most New Opportunities
• 24.3 Global Bioprocessing Market In 2029 - Growth Strategies
  • 24.3.1 Market Trend Based Strategies
  • 24.3.2 Competitor Strategies

25 Bioprocessing Market, Conclusions And Recommendations

• 25.1 Conclusions
• 25.2 Recommendations
  • 25.2.1 Product
  • 25.2.2 Place
  • 25.2.3 Price
  • 25.2.4 Promotion
  • 25.2.5 People

26 Appendix

• 26.1 Geographies Covered
• 26.2 Market Data Sources
• 26.3 Research Methodology
• 26.4 Currencies
• 26.5 The Business Research Company
• 26.6 Copyright and Disclaimer